Han Meilan K, Kim Min Gayles, Mardon Russell, Renner Phil, Sullivan Sean, Diette Gregory B, Martinez Fernando J
Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-0360, USA.
Chest. 2007 Aug;132(2):403-9. doi: 10.1378/chest.06-2846. Epub 2007 Jun 5.
COPD is a significant cause of morbidity and mortality. Guidelines recommend the confirmation of a COPD diagnosis with spirometry. Limited evidence exists, however, documenting the frequency of spirometry use in clinical practice.
The National Committee for Quality Assurance recruited five health plans to determine the proportion of patients >/= 40 years old with a new diagnosis of COPD who had received spirometry during the interval starting 720 days prior to diagnosis and ending 180 days after diagnosis. Patients were identified via International Classification of Diseases, Ninth Revision diagnostic codes for encounters during the period July 1, 2002, through June 30, 2003. For each patient, the participating plans provided patient demographic and claims data from administrative data systems.
Participating health plans covered 1,597,749 members with a total of 5,039 eligible COPD patients identified. Patients in the 40 to 64 age range had the highest percentage of new COPD diagnoses. Women were also slightly more likely to undergo spirometry (33.5% vs 29.4%, p = 0.001). Approximately 32% of patients with a new diagnosis of COPD had undergone spirometry in the specified interval. Spirometry frequency was lowest in older patients, with the lowest frequency in those >/= 75 years old.
Our study suggests that approximately 32% of a broad range of patients with a new COPD diagnosis had undergone spirometry within the previous 2 years to 6 months following diagnosis. In addition, spirometric testing appeared to decrease with increasing age. As opposed to a prior report, women were not less likely to have undergone spirometry. This study shows that spirometry is infrequently used in clinical practice for diagnosis of COPD and suggests opportunities for practice improvement.
慢性阻塞性肺疾病(COPD)是发病和死亡的重要原因。指南建议通过肺功能测定来确诊COPD。然而,关于肺功能测定在临床实践中的使用频率,现有证据有限。
国家质量保证委员会招募了5个健康计划,以确定年龄≥40岁、新诊断为COPD的患者中,在诊断前720天开始至诊断后180天结束的时间段内接受肺功能测定的患者比例。通过2002年7月1日至2003年6月30日期间国际疾病分类第九版诊断编码来识别患者。对于每位患者,参与计划的机构提供了来自行政数据系统的患者人口统计学和索赔数据。
参与的健康计划覆盖了1,597,749名成员,共识别出5,039名符合条件的COPD患者。40至64岁年龄组的新COPD诊断比例最高。女性接受肺功能测定的可能性也略高(33.5%对29.4%,p = 0.001)。新诊断为COPD的患者中约32%在指定时间段内接受了肺功能测定。肺功能测定频率在老年患者中最低,≥75岁的患者频率最低。
我们的研究表明,在新诊断为COPD的广泛患者中,约32%在诊断后的前2年至6个月内接受了肺功能测定。此外,肺功能测定的使用率似乎随着年龄的增加而降低。与之前的报告相反,女性接受肺功能测定的可能性并不低。这项研究表明,肺功能测定在临床实践中很少用于COPD的诊断,并提示了实践改进的机会。